Page last updated: 2024-10-23

bisindolylmaleimide i and T-Cell Lymphoma

bisindolylmaleimide i has been researched along with T-Cell Lymphoma in 2 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamir, A1
Granot, Y1
Isakov, N1
Cremaschi, GA1
Genaro, AM1
Cazaux, CA1
Anesini, C1
Wald, M1
Borda, T1
Sterin-Borda, L1

Other Studies

2 other studies available for bisindolylmaleimide i and T-Cell Lymphoma

ArticleYear
Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Aug-15, Volume: 157, Issue:4

    Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Bucladesine; Calcium-Calmodulin-Dependent Protein K

1996
Altered beta-adrenoceptor function associated to protein kinase C activation in hyperproliferative T lymphocytes.
    Journal of neuroimmunology, 2000, Oct-02, Volume: 110, Issue:1-2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenylyl Cyclases; Adrenergic beta-Agonists; Cell Div

2000